MedPath

Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography

Completed
Conditions
Left Ventricular Hypertrophy
Registration Number
NCT02221141
Lead Sponsor
Laurence Gabriel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - unexplained left ventricular hypertrophy<br><br>Exclusion Criteria:<br><br> - isolated septal hypertrophy

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath